Spots Global Cancer Trial Database for endometrial
Every month we try and update this database with for endometrial cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED) | NCT00122343 | Endometrial Can... | ridaforolimus | 18 Years - | Merck Sharp & Dohme LLC | |
| SLNM in Endometrial Cancer Combined With OSNA | NCT02826291 | Endometrial Can... | RD-100i, OSNA | 18 Years - | Charles University, Czech Republic | |
| Pelvic Fractures and Radiation Therapy for Cervical Cancer | NCT00800644 | Cervical Cancer Endometrial Can... Vaginal Cancer | CT or MRI + Blo... | - | M.D. Anderson Cancer Center | |
| Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies | NCT02485119 | Neoplasms | BAY94-9343 | 20 Years - | Bayer | |
| A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma | NCT04814108 | Uterine Serous ... | ZN-c3 | 18 Years - | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma | NCT03395080 | Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma | Paclitaxel 300mg DKN-01 600mg DKN-01 | 18 Years - | Leap Therapeutics, Inc. | |
| Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) | NCT02423954 | Advanced Cancer Pancreatic Canc... Renal Cell Canc... Non Small Cell ... Colorectal Carc... Endometrial Uterine | Temsirolimus Irinotecan Irinotecan + ca... nivolumab | 18 Years - | Western Regional Medical Center | |
| Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma | NCT00050440 | Endometrial Neo... Uterine Neoplas... Genital Neoplas... | Trabectedin Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma | NCT04814108 | Uterine Serous ... | ZN-c3 | 18 Years - | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | |
| Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers | NCT00319748 | Breast Cancer Ovarian Cancer Endometrial Can... Cervical Cancer | 852A | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer | NCT01512810 | Endometrial Can... | Lymphadenectomy | 18 Years - | University of Kentucky | |
| Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors | NCT02715284 | Neoplasms | Dostarlimab | 18 Years - | Tesaro, Inc. | |
| RAD001 in Recurrent Endometrial Cancer Patients | NCT00087685 | Endometrial Can... | RAD001 | - | M.D. Anderson Cancer Center | |
| Laparoscopic Approach to Cancer of the Endometrium | NCT00096408 | Endometrial Can... | Total Abdominal... Total Laparosco... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
| Trial of Maintenance With Niraparib- Uterine Serous Carcinoma | NCT04080284 | Endometrial Can... Papillary Serou... Uterine Serous ... Endometrial Car... Cancer of the E... | Niraparib | 18 Years - | Northwell Health | |
| Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy | NCT00909896 | Endometrial Can... | 18 Years - 85 Years | Ohio State University Comprehensive Cancer Center | ||
| A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer | NCT02922764 | Endometrial Can... Endometrial Can... Lung Cancer Rec... Lung Cancer Non-small Cell ... Non-small Cell ... | RGX-104 Ipilimumab Docetaxel Pembrolizumab Carboplatin Pemetrexed | 18 Years - | Inspirna, Inc. | |
| AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED) | NCT00122343 | Endometrial Can... | ridaforolimus | 18 Years - | Merck Sharp & Dohme LLC | |
| Pelvic Fractures and Radiation Therapy for Cervical Cancer | NCT00800644 | Cervical Cancer Endometrial Can... Vaginal Cancer | CT or MRI + Blo... | - | M.D. Anderson Cancer Center | |
| Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | NCT03170960 | Urothelial Carc... Renal Cell Carc... Non-Small Cell ... Castration-resi... Triple Negative... Ovarian Cancer Endometrial Can... Hepatocellular ... Gastric Cancer Gastroesophagea... Colorectal Canc... Head and Neck C... Differentiated ... Lower Esophagea... | cabozantinib atezolizumab cabozantinib cabozantinib | 18 Years - | Exelixis | |
| Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors | NCT04681248 | Esophageal Neop... Adenocarcinoma ... GastroEsophagea... Squamous Cell C... Gastric Adenoca... Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma Gastric Cancer | DKN-01 | 18 Years - | Leap Therapeutics, Inc. | |
| A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors | NCT02743637 | Advanced Malign... Advanced Solid ... Neoplasm Metastasis | SDX-7320 | 21 Years - 85 Years | SynDevRx, Inc. | |
| Laparoscopic Approach to Cancer of the Endometrium | NCT00096408 | Endometrial Can... | Total Abdominal... Total Laparosco... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
| A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas | NCT01588678 | Advanced Solid ... Lymphoma | DS-3078a | 18 Years - | Daiichi Sankyo | |
| Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer | NCT04586959 | ENDOMETRIAL CAN... | Surgery with UM Surgery without... | 18 Years - 90 Years | Baylor College of Medicine | |
| A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study | NCT01271959 | Solid Organ Tum... | 18 Years - | Precision Therapeutics | ||
| RAD001 in Recurrent Endometrial Cancer Patients | NCT00087685 | Endometrial Can... | RAD001 | - | M.D. Anderson Cancer Center | |
| Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) | NCT02423954 | Advanced Cancer Pancreatic Canc... Renal Cell Canc... Non Small Cell ... Colorectal Carc... Endometrial Uterine | Temsirolimus Irinotecan Irinotecan + ca... nivolumab | 18 Years - | Western Regional Medical Center | |
| Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? | NCT03570437 | Carcinosarcoma Endometrial Neo... | Paclitaxel Cediranib Olaparib | 16 Years - | University of Manchester | |
| Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers | NCT00319748 | Breast Cancer Ovarian Cancer Endometrial Can... Cervical Cancer | 852A | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations | NCT05199584 | Solid Tumors Wi... | ENV-101 (talade... | 18 Years - | Endeavor Biomedicines, Inc. | |
| Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols | NCT00026689 | Prostate Brain Breast Lung Endometrial | - 90 Years | National Institutes of Health Clinical Center (CC) | ||
| Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy | NCT00900562 | Uterine Cervica... Endometrial Can... | Zalypsis ( PM00... | 18 Years - | PharmaMar | |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma | NCT03395080 | Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma | Paclitaxel 300mg DKN-01 600mg DKN-01 | 18 Years - | Leap Therapeutics, Inc. | |
| Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) | NCT00507741 | Ovarian Cancer Endometrial Can... | Vintafolide Ertafolide | 18 Years - | Endocyte | |
| Trisenox® in Women With Metastatic Endometrial Cancer | NCT01184053 | Endometrial Car... | Arsenic trioxid... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| SLNM in Endometrial Cancer Combined With OSNA | NCT02826291 | Endometrial Can... | RD-100i, OSNA | 18 Years - | Charles University, Czech Republic | |
| CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | NCT03454451 | Non-Small Cell ... Renal Cell Canc... Colorectal Canc... Triple Negative... Cervical Cancer Ovarian Cancer Pancreatic Canc... Endometrial Can... Sarcoma Squamous Cell C... Bladder Cancer Metastatic Cast... Non-hodgkin Lym... | CPI-006 CPI-006 + cifor... CPI-006 + pembr... CPI-006 CPI-006 + cifor... CPI-006 + pembr... | 18 Years - | Corvus Pharmaceuticals, Inc. | |
| Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy | NCT00909896 | Endometrial Can... | 18 Years - 85 Years | Ohio State University Comprehensive Cancer Center | ||
| Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer | NCT05997017 | Endometrial Can... Endometrioid Tu... Cancer Tumor Recurrent Endom... Endometrioid En... | nab-sirolimus | 18 Years - | Aadi Bioscience, Inc. | |
| Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma | NCT00050440 | Endometrial Neo... Uterine Neoplas... Genital Neoplas... | Trabectedin Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Laparoscopic Approach to Cancer of the Endometrium | NCT00096408 | Endometrial Can... | Total Abdominal... Total Laparosco... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
| A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors | NCT02743637 | Advanced Malign... Advanced Solid ... Neoplasm Metastasis | SDX-7320 | 21 Years - 85 Years | SynDevRx, Inc. | |
| ATAC - Endometrial Sub-Protocol | NCT00814125 | Breast Cancer | Anastrozole (Ar... Tamoxifen (Nolv... Nolvadex placeb... Arimidex placeb... | 45 Years - | AstraZeneca | |
| ATAC - Endometrial Sub-Protocol | NCT00814125 | Breast Cancer | Anastrozole (Ar... Tamoxifen (Nolv... Nolvadex placeb... Arimidex placeb... | 45 Years - | AstraZeneca | |
| Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols | NCT00026689 | Prostate Brain Breast Lung Endometrial | - 90 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
